Does progesterone exert anti-androgen effects by inhibiting 5α-reductase and reducing androgen receptor signaling?

Progesterone functions as a natural modulator of androgenic activity through two primary pathways: the competitive inhibition of potent androgen production and the transcriptional regulation of the androgen receptor itself.

5α-reductase inhibition

Progesterone acts as a competitive substrate for the 5α-reductase enzyme, the protein responsible for converting testosterone into dihydrotestosterone (DHT), which is significantly more potent.

• Enzyme Competition: Because progesterone has a high affinity for the 5α-reductase enzyme (isoforms SRD5A1 and SRD5A2), it competes directly with testosterone for the enzyme’s active site. In effect, the enzyme processes progesterone into 5α-pregnanes instead of converting testosterone into DHT.
• Inhibitory Potency: In vitro research using human genital skin fibroblasts has shown that progesterone can reduce 5α-reductase activity by as much as 97%. By limiting the local conversion to DHT, progesterone reduces the total androgenic burden in target tissues like the skin and hair follicles.

Reduction of androgen receptor signaling

Beyond reducing DHT levels, progesterone actively dampens the cellular response to androgens by decreasing the availability of the androgen receptor (AR).

• Transcriptional Repression: When progesterone binds to its own receptor (PR), the activated complex can directly downregulate the expression of the AR gene. This process involves hormone-dependent histone deacetylation and chromatin looping that silences the AR promoter, leading to fewer androgen receptors being produced by the cell.
• Net Anti-Androgen Effect: While progesterone itself has low binding affinity for the androgen receptor and does not act as a traditional receptor antagonist (like spironolactone), the combination of lowering DHT levels and reducing the number of available receptors results in a significant functional decrease in androgen signaling.

Bottom line

Progesterone exhibits anti-androgenic effects by acting as a competitive inhibitor of 5α-reductase and by transcriptionally downregulating the androgen receptor. This dual action effectively lowers the production of potent androgens and reduces the cell's overall sensitivity to androgenic stimuli.